Riskpilot← Back to searchSign inGet full accessRESTPAD Scandinavia AB
ABActiveOrg 5568424252Linnégatan 18 6trWholesale of pharmaceutical and medical goods · NACE 4646Est. 20110 employees
Revenue 2025
SEK 7K
-46% vs 2024
EBITDA margin
-2314.3%
+39% vs 2024
Equity ratio
9.5%
Financial strength
Net profit 2025
SEK -364K
+22% vs 2024
| Revenue | SEK 7K | -46% |
| EBITDA | SEK -162K | +39% |
| Net profit | SEK -364K | +22% |
| Total assets | SEK 1,3M | -1% |
| Equity | SEK 121K | +9% |
| Employees | 0 | — |
Legal name
RESTPAD Scandinavia AB
Org number
5568424252
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
17 februari 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva utveckling och försäljning av medicinteknisk utrustning jämte därmed förenlig verksamhet.
Address
Linnégatan 18 6tr
Email
oskar.svensson@runsvengruppen.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 35 | 17 | 19 | 13 | 7 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −238 | −243 | −197 | −267 | −162 |
| Depreciation & amort. | −238 | −203 | −122 | −107 | −117 |
| EBIT | −476 | −446 | −319 | −374 | −279 |
| Net financials | −75 | −53 | −80 | −94 | −86 |
| Profit before tax | −552 | −498 | −399 | −468 | −364 |
| Tax | −0 | −0 | — | −0 | −0 |
| Net profit | −552 | −498 | −399 | −468 | −364 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 417 | 1 593 | 1 424 | 1 292 | 1 273 |
| Equity | 76 | 278 | 179 | 111 | 121 |
| Long-term debt | 1 214 | 1 159 | 1 099 | 1 039 | 700 |
| Short-term debt | 127 | 157 | 147 | 142 | 452 |
| Total debt | 1 341 | 1 316 | 1 245 | 1 181 | 1 152 |
EBITDA margin
-2314.3%
This company
15.8%
Market median
-14747% vs market
20212025
Equity ratio
9.5%
This company
38.2%
Market median
-75% vs market
20212025
Return on equity
-300.8%
This company
18.4%
Market median
-1735% vs market
20212025
Net profit margin
-5200.0%
This company
8.1%
Market median
-64298% vs market
20212025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20212025
Debt / equity
9.52×
This company
0.62×
Market median
-1435% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CH Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RESTPAD Scandinavia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Clas Henrik Tegidius | Audit | 0 companies |
| Oskar Tomas Svensson | Board of Directors | 0 companies |
| Kathrine Holm Svensson | Deputy Board Member | 0 companies |